• Home
  • Study Details
Not currently enrolling

Limit JIA

To evaluate the effectiveness of a 24-week course of treatment with abatacept (orencia) versus usual care to prevent patients from developing more active joints.

Age & Gender

  • 2 years ~ 16 years
  • Male, Female, Gender Inclusive

Contact the Team


Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Laura Cannon
Pediatrics - Children's Research Institute

Study Type

Clinical or Medical

Study Topics

Bones, Joints, Muscles
Child and Teen Health
Immune System/Infections

IRB Number




Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research